No-Transcatheter Aortic Valve Replacement (TAVR) Zones and Their Effect on Access to Care for Medicare Beneficiaries with Aortic Stenosis
This study highlights the critical role of geographic and socioeconomic barriers in accessing advanced medical treatments like TAVR. Addressing these barriers may ensure equitable healthcare distribution, guiding policymakers and providers towards more accessible healthcare solutions for all populations.
Authors
- Jay Giri (ORCID: https://orcid.org/0000-0002-8076-0098)
- Candace Gunnarsson (ORCID: https://orcid.org/0000-0003-0723-585X)
- Christin Thompson (ORCID: https://orcid.org/0000-0002-4713-4730)
- Seth Clancy
- Michael P. Ryan (ORCID: https://orcid.org/0000-0002-7207-7926)
- Ashwin S. Nathan (ORCID: https://orcid.org/0000-0002-7227-6423)
- Guy David (ORCID: https://orcid.org/0000-0001-9191-741X)
- Andrew J. Epstein (ORCID: https://orcid.org/0000-0001-5078-6564)
- Soumya Chikermane (ORCID: https://orcid.org/0000-0001-5335-3430)
Institutions
- McKesson (United States) (US)
- Edwards Lifesciences (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1007/s12325-025-03116-8
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- Edwards Lifesciences